Captrust Financial Advisors Jazz Pharmaceuticals PLC Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Captrust Financial Advisors holds 4,535 shares of JAZZ stock, worth $579,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,535

Previous 4,793 5.38%

Holding current value

$579,300

Previous $577,000 16.12%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$103.94 - $118.98 $26,816 - $30,696	-258 Reduced 5.38%	4,535 $484,000
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $60,129 - $69,305	-522 Reduced 9.82%	4,793 $577,000
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $18,053 - $21,488	-158 Reduced 2.89%	5,315 $653,000
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $888,282 - $1.06 Million	-7,281 Reduced 57.09%	5,473 $708,000
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $958,562 - $1.15 Million	7,825 Added 158.75%	12,754 $1.58 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $23,982 - $28,724	179 Added 3.77%	4,929 $721,000
Q4 2022 Feb 15, 2023	SELL	$129.72 - $159.85 $20,236 - $24,936	-156 Reduced 3.18%	4,750 $756,000
Q3 2022 Nov 16, 2022	BUY	$126.59 - $161.18 $149,376 - $190,192	1,180 Added 31.67%	4,906 $654,000
Q2 2022 Aug 23, 2022	SELL	$141.59 - $168.66 $165,943 - $197,669	-1,172 Reduced 23.93%	3,726 $581,000
Q2 2022 Aug 16, 2022	BUY	$141.59 - $168.66 $168,633 - $200,874	1,191 Added 32.13%	4,898 $764,000
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $11,149 - $13,820	86 Added 2.38%	3,707 $577,000
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $28,768 - $34,960	240 Added 7.1%	3,621 $461,000
Q3 2021 Nov 16, 2021	SELL	$128.64 - $184.79 $13,764 - $19,772	-107 Reduced 3.07%	3,381 $440,000
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $40,050 - $46,605	250 Added 7.72%	3,488 $620,000
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $62,779 - $72,523	418 Added 14.82%	3,238 $532,000
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $15,478 - $18,155	110 Added 4.06%	2,820 $465,000
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $57,886 - $73,737	-605 Reduced 18.25%	2,710 $297,000
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $46,063 - $80,188	-525 Reduced 13.67%	3,315 $317,000
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $425,893 - $556,502	3,620 Added 1645.45%	3,840 $570,000
Q2 2019 Aug 13, 2019	BUY	$125.55 - $144.48 $15,066 - $17,337	120 Added 120.0%	220 $31,000
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $1,705 - $2,001	-14 Reduced 12.28%	100 $14,000
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $1,623 - $2,334	14 Added 14.0%	114 $14,000
Q3 2018 Nov 15, 2018	BUY	$161.01 - $180.57 $16,101 - $18,057	100 New	100 $17,000

Others Institutions Holding JAZZ

# of Institutions

503

Shares Held

58.1M

Call Options Held

170K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.01B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Jazz Pharmaceuticals PLC Transaction History